€ million |
|
Q2 2025 |
|
Q2 2026 |
|
H1 2025 |
|
H1 2026 |
|||
|---|---|---|---|---|---|---|---|---|---|---|---|
Income after income taxes |
|
(190) |
|
229 |
|
1,114 |
|
2,996 |
|||
of which attributable to noncontrolling interest |
|
9 |
|
10 |
|
14 |
|
14 |
|||
of which attributable to Bayer AG stockholders |
|
(199) |
|
219 |
|
1,100 |
|
2,982 |
|||
Remeasurements of the net defined benefit liability for post-employment benefit plans |
|
100 |
|
390 |
|
519 |
|
76 |
|||
Income taxes |
|
(1) |
|
7 |
|
(140) |
|
11 |
|||
Other comprehensive income from remeasurements of the net defined benefit liability for post-employment benefit plans |
|
99 |
|
397 |
|
379 |
|
87 |
|||
Changes in the fair value of equity instruments measured at fair value |
|
(13) |
|
3 |
|
(22) |
|
(1) |
|||
Income taxes |
|
4 |
|
(1) |
|
4 |
|
(1) |
|||
Other comprehensive income from equity instruments measured at fair value |
|
(9) |
|
2 |
|
(18) |
|
(2) |
|||
Other comprehensive income relating to associates accounted for using the equity method |
|
– |
|
– |
|
– |
|
1 |
|||
Other comprehensive income that will not be reclassified subsequently to profit or loss |
|
90 |
|
399 |
|
361 |
|
86 |
|||
Changes in the fair value of cash flow hedges |
|
146 |
|
(3) |
|
143 |
|
(2) |
|||
Reclassified to profit or loss |
|
(37) |
|
(70) |
|
(42) |
|
(85) |
|||
Income taxes |
|
(39) |
|
17 |
|
(36) |
|
37 |
|||
Other comprehensive income from cash flow hedges |
|
70 |
|
(56) |
|
65 |
|
(50) |
|||
Changes in time value of options used as hedging instrument |
|
– |
|
4 |
|
6 |
|
(11) |
|||
Income taxes |
|
(1) |
|
(1) |
|
(2) |
|
3 |
|||
Other comprehensive income from time value of options |
|
(1) |
|
3 |
|
4 |
|
(8) |
|||
Changes in exchange differences recognized on translation of operations outside the eurozone |
|
(2,001) |
|
286 |
|
(3,040) |
|
807 |
|||
Reclassified to profit or loss |
|
– |
|
(1) |
|
– |
|
(1) |
|||
Other comprehensive income from exchange differences |
|
(2,001) |
|
285 |
|
(3,040) |
|
806 |
|||
Other comprehensive income relating to associates accounted for using the equity method |
|
16 |
|
(3) |
|
23 |
|
(9) |
|||
Other comprehensive income that may be reclassified subsequently to profit or loss |
|
(1,916) |
|
229 |
|
(2,948) |
|
739 |
|||
Total other comprehensive income1 |
|
(1,826) |
|
628 |
|
(2,587) |
|
825 |
|||
of which attributable to noncontrolling interest |
|
(13) |
|
2 |
|
(19) |
|
(1) |
|||
of which attributable to Bayer AG stockholders |
|
(1,813) |
|
626 |
|
(2,568) |
|
826 |
|||
Total comprehensive income |
|
(2,016) |
|
857 |
|
(1,473) |
|
3,821 |
|||
of which attributable to noncontrolling interest |
|
(4) |
|
12 |
|
(5) |
|
13 |
|||
of which attributable to Bayer AG stockholders |
|
(2,012) |
|
845 |
|
(1,468) |
|
3,808 |
|||
|
|||||||||||